Subscribe
shutterstock_1169047330_markvanscyoc-1
markvanscyoc / shutterstock.com
6 September 2022Big PharmaStaff Writer

USPTO unveils tool to access key FDA data

Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
USPTO and FDA unite to tackle drug pricing
7 July 2022   The US Patent and Trademark Office and Food and Drug Administration have partnered to facilitate access to affordable drugs.
article
USPTO told to avoid negative focus on patent thickets
28 February 2023   Pharma trade body highlighted negative narratives involving continuation patents | Such IP “essential for ongoing research and development” | USPTO requested comments following criticism of patent thickets.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Big Pharma
USPTO and FDA unite to tackle drug pricing
7 July 2022   The US Patent and Trademark Office and Food and Drug Administration have partnered to facilitate access to affordable drugs.
article
USPTO told to avoid negative focus on patent thickets
28 February 2023   Pharma trade body highlighted negative narratives involving continuation patents | Such IP “essential for ongoing research and development” | USPTO requested comments following criticism of patent thickets.

More on this story

Big Pharma
USPTO and FDA unite to tackle drug pricing
7 July 2022   The US Patent and Trademark Office and Food and Drug Administration have partnered to facilitate access to affordable drugs.
article
USPTO told to avoid negative focus on patent thickets
28 February 2023   Pharma trade body highlighted negative narratives involving continuation patents | Such IP “essential for ongoing research and development” | USPTO requested comments following criticism of patent thickets.

More features

Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court
Cooley adds ex-Gowling partner